Company Analysis

SL Science Holding Limited (SLBT)

Nasdaq: SLBT · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2025
Grade5.2
◀ Past 5.9● Present 5.0▶ Future 5.0
8 est.

Who runs SL Science Holding Limited

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Wang Ching-Dong
Chief Executive Officer. First filing Jun 2026, latest Oct 1, 2026, 1 filing in all.
Officers reporting now
4
of 9 people with a filing in the last fifteen months
Directors reporting now
5
9 people on the record since 2026
Officerssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Shen Ethan PhdChief Technology OfficerJun 2026Nov 3, 2026none
Wang Ching-DongChief Executive OfficerJun 2026Oct 1, 2026none
Lau Johnson Shun-PongVice President of FinanceJun 2026Sep 1, 2026none
Leung Lok SangChief Financial OfficerJun 2026Jun 16, 2026none
Directorssales are open-market, Nov 3, 2025 to Nov 3, 2026
NameRoleFirst filingLatest filingSales, 12 months
Xu QiandirectorJun 2026Jun 17, 2026none
Chen Kwo-LiangdirectorJun 2026Jun 16, 2026none
General John ConraddirectorJun 2026Jun 16, 2026none
Liu MingchedirectorJun 2026Jun 16, 2026none
Levinson JosephdirectorJun 2026Jun 15, 2026none

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SLBT · research, not advice